How Long for Test E to Kick In: Week-by-Week Effects

Testosterone enanthate (Test E) begins raising blood levels within hours of injection, but the physical and psychological effects you actually feel roll in over weeks and months depending on the system involved. Serum testosterone spikes to several times the normal range within the first day and then gradually settles into a rhythm as injections continue. The timeline for noticeable changes, though, spans from about three weeks for mood and libido up to a full year or more for bone density, with body composition and strength improvements landing somewhere in between.

How Fast Blood Levels Rise

Test E has a half-life of roughly four and a half days, which is why most protocols call for injections every one to two weeks.

¹ After a single intramuscular shot, serum testosterone reaches supraphysiological levels within just a few hours, with peak concentrations hitting four to five times above baseline somewhere between 8 and 24 hours post-injection.² By about nine days after that single dose, levels drift back down to baseline. This rise-and-fall pattern is why repeated dosing is necessary, and why it takes multiple injections before your body reaches a stable, elevated concentration of testosterone.

How quickly you reach that stable state depends on how often you inject. Modeling studies in adolescent males found that weekly subcutaneous injections reached steady-state concentrations by around the ninth dose, while every-other-week dosing got there by the fifth injection and monthly dosing by the third.³ In practical terms, most people on a standard every-other-week protocol are approaching pharmacological steady state by about 10 weeks. That is the point where blood levels stop climbing with each new injection and instead oscillate within a predictable range.

Weeks 1 Through 3: Mood, Energy, and the First Hints of Libido

The earliest effects people actually notice tend to be psychological. Research in hypogonadal men shows that improvements in mood parameters like energy, well-being, and friendliness, along with decreases in anger, sadness, and irritability, begin emerging within the first few weeks of treatment.⁴ A large review of onset timelines found that improvements in mood and decreases in depressive symptoms can start as early as three weeks, with increases in motivation documented by about 30 days.⁵

Sexual interest tends to follow a similar early timeline. Effects on libido appear after roughly three weeks and plateau by about six weeks, with no further increases expected after that point.⁶ This is one of the quicker effects to materialize, and for many men on testosterone replacement therapy (TRT), it is the first concrete sign that the treatment is doing something.

Not everything that happens early is pleasant. Fluid retention can begin in the first weeks. Testosterone increases extracellular water, and this effect appears to act directly on the kidneys rather than through the hormonal systems that normally regulate fluid balance.⁷ The scale may jump a few pounds before any actual muscle tissue has been built, and some puffiness around the face, hands, or ankles is not uncommon. This early water weight gain is often mistaken for rapid muscle growth.

Weeks 3 Through 6: Mood Deepens, Some Side Effects Appear

Between weeks three and six, the mood improvements that started earlier tend to consolidate. Decreases in fatigue and listlessness have been documented by about one month, and several psychological variables like sociability, concentration, and self-confidence show measurable improvement in that same window.⁵ Depression scores tend to improve by six to eight weeks on standardized rating scales, though maximum mood benefit may not arrive for another four to seven months.

This period is also when acne can start showing up. Testosterone-driven acne is a well-known androgenic side effect, typically mild, that peaks within the first six months of therapy. It tends to improve gradually during the first year, though for some people it sticks around longer.⁸ In a large multicenter study of men receiving Test E specifically, the most commonly reported side effects were injection-site soreness, acne, fatigue, and weight gain.⁹

It is worth noting that a transient bump in anger or hostility has been observed around two weeks in men whose testosterone levels were pushed above the normal range. This was not seen in hypogonadal men being brought back to normal levels; it was specific to supraphysiological dosing.⁵ If you are using Test E at replacement doses, this is less of a concern than the internet would have you believe.

Weeks 6 Through 12: Body Composition Begins to Shift

By about six weeks, the hormonal environment in your body has been consistently elevated long enough for slower-moving tissue changes to begin. This is when lean mass starts to accrue and fat mass starts to decline in a measurable way, though the effect builds gradually rather than appearing all at once.

A study in hypogonadal men receiving 100 mg per week of Test E for 10 weeks found that fat-free mass increased by about 5 kg and triceps and quadriceps cross-sectional area both grew significantly, as measured by MRI.¹⁰ Research tracking body composition with wearable technology found that lean mass gains were largest early in the supplementation period and continued at a slower rate during a second phase, while body fat percentage declined in both phases.¹¹ In adolescents with delayed puberty treated with testosterone, fat-free mass increased and fat mass decreased significantly after four months.¹²

Hemoglobin and hematocrit, the measures of red blood cell mass, also begin climbing within the first month and continue rising past week 12. In a graded-dose study of healthy men, the majority of participants, especially those on higher doses and older individuals, did not reach peak hematocrit until after week 12.¹³ Elevated hematocrit can thicken the blood and is the reason most physicians order periodic blood work once you are on TRT, typically checking at around three months and then at regular intervals.

Months 3 Through 6: Strength Gains, Metabolic Improvements, and Prostate Markers

Measurable strength gains typically lag behind the body composition changes. Evidence indicates that effects on muscle strength become demonstrable at around 12 to 20 weeks, with maximum strength reached somewhere between 6 and 12 months depending on the testosterone levels achieved.¹⁴ One caveat here: in a study of men over 65 brought to midnormal testosterone levels, lean mass increased and fat mass decreased, but knee extension and flexion strength did not significantly improve compared to placebo.¹⁵ Age, baseline fitness, training status, and the testosterone level actually achieved all influence whether the added muscle tissue translates into functional strength.

Erectile function improvements may also appear in this window. While libido typically plateaus by week six, changes in erections and ejaculatory function can take up to six months to fully develop.⁶ If you noticed a bump in desire early on but have not seen corresponding improvements in physical function, the research suggests patience rather than a dose increase.

Metabolic markers shift in this period as well. In hypogonadal men with type 2 diabetes, testosterone therapy improved fasting insulin sensitivity, reduced glycated hemoglobin, and lowered fasting blood glucose.¹⁶ These changes reflect the interplay between rising lean mass, declining fat mass, and testosterone’s direct effects on glucose handling.

Prostate-specific antigen (PSA) levels also begin rising. In severely hypogonadal men, median PSA roughly tripled in the first one to three months of treatment, rising from 0.30 ng/mL at baseline to 0.95 ng/mL, and continued climbing modestly to 1.20 ng/mL between months 6 and 18.¹⁷ The PSA rise generally brings men up to the normal range for their age rather than into a danger zone, but it is why baseline PSA testing before starting and periodic checks afterward are standard practice.¹⁸

What Happens to Your Cholesterol

Lipid changes are a frequent concern with exogenous testosterone. Meta-analyses of TRT studies have generally found that treatment lowers HDL cholesterol, though this often occurs alongside decreases in total cholesterol and LDL cholesterol as well.¹⁹ A year-long study of older men on transdermal testosterone found that HDL dropped significantly while total cholesterol, triglycerides, and LDL did not change.²⁰ The practical takeaway is that your HDL is likely to take a hit regardless of the route of administration, and this warrants monitoring, especially if you already have cardiovascular risk factors. The timeline for these lipid changes is not as tightly characterized as for mood or body composition, but they tend to be detectable within the first few months.

Six Months and Beyond: Bone Density and Long-Term Remodeling

The slowest system to respond is bone. Bone remodeling operates on a cycle of months, so meaningful density changes take time to accumulate. In a controlled trial of older men with low testosterone, one year of treatment increased lumbar spine trabecular bone density by about 7.5% compared to less than 1% with placebo, and estimated spine bone strength increased by roughly 11%.²¹ Hip bone density also increased, though the gains were smaller than at the spine.

Long-term data in hypogonadal men shows that the most dramatic bone density increase happens during the first year of testosterone treatment, with gains continuing at a slower pace after that.²² A systematic review and meta-analysis confirmed that TRT improves bone density at the spine and femoral neck, with larger effects seen in men who started with lower testosterone levels and in studies of longer duration.²³ If bone health is one of your reasons for starting TRT, expect to measure progress in years rather than weeks.

Why Your Timeline Might Differ from Someone Else’s

The week-by-week framework above reflects averages drawn from clinical studies, but individual variation is substantial. Several factors shift the timeline forward or back for a given person.

Starting testosterone level matters a great deal. A man whose baseline is extremely low is likely to feel mood and energy effects sooner and more dramatically than someone starting from the low-normal range. The bone density meta-analysis found that subjects with lower baseline testosterone saw greater improvements, and the same pattern appears in body composition research.²³

Age also plays a role. Older men tend to see hematocrit peaks later and at higher levels than younger men on the same dose.¹³ The relationship between lean mass gain and actual strength improvement may also be weaker in older adults, as the study of men over 65 demonstrated. Injection route matters too: subcutaneous injections produce average blood levels about 75% of what intramuscular injections deliver at equivalent doses, meaning the effective exposure and thus the rate of downstream effects may differ.³

Body composition at baseline, the presence of metabolic conditions like diabetes, injection frequency, dose, and individual variation in how quickly you metabolize the ester all contribute. Two people on the same protocol can have meaningfully different blood level curves and, by extension, different experienced timelines for effects.

The Difference Between Feeling It and Seeing It

One of the most common frustrations for people starting Test E is the gap between subjective and objective changes. You may feel better, more energetic, and more interested in sex within the first month, but the mirror and the gym logbook may not confirm anything for another two to three months. This is not a sign that the treatment is failing. The psychological effects of testosterone rely on receptor activation in the brain, which responds relatively quickly to rising hormone levels. Muscle protein synthesis, fat metabolism, and red blood cell production are slower physiological processes that require weeks of sustained hormonal stimulation before they produce visible or measurable changes.

The early weight gain is another common source of confusion. The combination of water retention and a modest increase in appetite can add several pounds in the first few weeks, and because it is not yet accompanied by visible muscle definition, it can look and feel like the wrong kind of weight gain. This typically resolves as true lean tissue accumulates and fluid levels stabilize over the following months.

Skin, Hair, and Other Androgenic Effects

Beyond acne, testosterone can increase oiliness of the skin and accelerate androgenic hair changes. Body hair growth tends to increase over several months, while scalp hair loss, in men genetically predisposed to male-pattern baldness, may worsen. These effects are driven by the conversion of testosterone to dihydrotestosterone (DHT) and are dose-dependent. The acne timeline is the best-documented of these: onset in the first weeks to months, peak severity by six months, and gradual improvement through the first year.⁸ Hair-related changes are slower and more variable, tending to track with genetic susceptibility rather than any universal timeline.

One practical note: some people see dramatic skin changes while others on identical doses see none. If acne is becoming an issue, the standard approach is topical treatment first, with more aggressive options reserved for severe or persistent cases. Adjusting the testosterone dose or injection frequency can also help by reducing the magnitude of hormonal peaks and troughs.

Red Blood Cells and the Hematocrit Watch

The steady climb in hemoglobin and hematocrit that begins in the first month deserves its own discussion because it is the most common reason clinicians pause or adjust TRT. Testosterone stimulates the kidneys to produce more erythropoietin, which in turn drives the bone marrow to churn out more red blood cells. This is a feature of testosterone’s biology, not a flaw in the treatment. But if hematocrit climbs too high, the blood becomes more viscous and the risk of clotting events rises.

In the graded-dose study, the majority of treatment discontinuations due to elevated hematocrit occurred after week 12, and peak hematocrit was reached even later in older men and those on higher doses.¹³ A standard monitoring schedule involves checking a complete blood count at three months, six months, and then annually. If your hematocrit exceeds the threshold your doctor sets (commonly around 54%), the usual interventions are dose reduction, switching to more frequent lower-dose injections to reduce peak levels, or therapeutic blood donation to bring the count down acutely.

People living at high altitude or with conditions like sleep apnea may see hematocrit rise faster and higher, since both of those independently stimulate red blood cell production. If you fall into either category, more frequent monitoring early on is a sensible precaution.

1
ScienceDirect. Testosterone Enantate
2
PubMed. Comparative pharmacokinetics of testosterone enanthate and testosterone cyclohexanecarboxylate as assessed by serum and salivary testosterone levels in normal men
3
Journal of the Endocrine Society. Allometric Scaling of Testosterone Enanthate Pharmacokinetics to Adolescent Hypogonadal Males (IM and SC Administration)
4
The Journal of Clinical Endocrinology & Metabolism. Testosterone replacement therapy improves mood in hypogonadal men–a clinical research center study
5
European Journal of Endocrinology. Onset of effects of testosterone treatment and time span until maximum effects are achieved – Section: Time-course of effects on psychological variables
6
PubMed Central. Onset of effects of testosterone treatment and time span until maximum effects are achieved
7
The Journal of Clinical Endocrinology & Metabolism. Independent and Combined Effects of Testosterone and Growth Hormone on Extracellular Water in Hypopituitary Men
8
PubMed Central. Acne fulminans in a transgender boy after an increase in testosterone dosage – Section: Discussion
9
Fertility and Sterility. Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study
10
The Journal of Clinical Endocrinology & Metabolism. Testosterone Replacement Increases Fat-Free Mass and Muscle Size in Hypogonadal Men
11
PubMed Central. Dose-Response Effects of Exercise and Testosterone Replacement Therapy on Body Composition, Lean Mass, and Heart Rate Responses: A Case Report Using Wearable Technology
12
The Journal of Clinical Endocrinology & Metabolism. Testosterone Treatment in Adolescents with Delayed Puberty: Changes in Body Composition, Protein, Fat, and Glucose Metabolism
13
The Journal of Clinical Endocrinology & Metabolism. Effects of Graded Doses of Testosterone on Erythropoiesis in Healthy Young and Older Men
14
European Journal of Endocrinology. Onset of effects of testosterone treatment and time span until maximum effects are achieved – Section: Time-course of effects on muscle mass/strength
15
The Journal of Clinical Endocrinology & Metabolism. Effect of Testosterone Treatment on Body Composition and Muscle Strength in Men Over 65 Years of Age
16
PubMed. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes
17
Journal of the Endocrine Society. Prostate-Specific Antigen Concentrations in Response to Testosterone Treatment of Severely Hypogonadal Men
18
European Journal of Endocrinology. Onset of effects of testosterone treatment and time span until maximum effects are achieved – Section: Time-course of effects on the prostate
19
PubMed Central. An update on testosterone, HDL and cardiovascular risk in men
20
The Journals of Gerontology: Series A. Effects of Transdermal Testosterone on Lipids and Vascular Reactivity in Older Men With Low Bioavailable Testosterone Levels
21
PubMed Central. Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial
22
The Journal of Clinical Endocrinology & Metabolism. Long-Term Effect of Testosterone Therapy on Bone Mineral Density in Hypogonadal Men
23
PubMed. Testosterone supplementation and bone parameters: a systematic review and meta-analysis study